DFX Intelligence
The names on this page are hidden. Create a free account to reveal 5 records a month, or get Private Credit Intelligence at $249 a month for every name. Every figure, date and source on this page is public either way.
Borrower
I•••••••
Healthcare & Pharmaceuticalsgroup grade Aoff every schedule since Jun 30, 2025sponsor unattributed
Also written as: Equity Securities; The I••••••• Group
Nothing material in the last 200 days. Last change: 30 Jun 2025, Consensus mark 94¢ on cost, down from 102¢ a year ago, 101¢ last quarter.
Mark path, consensus per quarter end
102¢ · 103¢ · 101¢ · 101¢ · 94¢Q2 2024 to Q2 2025
Where each lender marks it on the first lien term loan, 1 point apart
93¢94¢
Principal held
at least $9.9M
sum of BDC pieces, a lower bound
Fair value
$9.2M
94c on cost, debt pieces
Unfunded
Not disclosed
commitments not yet drawn
BDC lenders
2
2 on the latest quarter
Facilities
3
1 equity pieces beside them
Next maturity
Dec 22, 2028
no dated debt inside 24 months
On the tape since
Dec 31, 2022
latest Jun 30, 2025
Events
5
dated, non-routine
Lender marks
each lender's own fair value over cost at Jun 30, 2025, folded to one row per lender
| Lender | Exposure | Current mark | QoQ change |
|---|---|---|---|
| A•••• P•••••• C••••• F•••• L•• | $6.07M | 93¢ | new this quarter |
| A•••• C••••• B•• I••• | $3.83M | 94¢ | -7 pts |
Every BDC piece · 4 positions across 2 lenderslargest principal first, with instrument and rate
| BDC | Instrument | Principal | Fair value | Rate |
|---|---|---|---|---|
| A•••• P•••••• C••••• F•••• L•• | term loan first lien Investment T••• Sr. S•••••• F•••• L••• I•••• S+ S••••• 6.50% I••••••• R••• 10.79% A••••••• | $6.1M | $5.6M 93c | SOFR+650 bp |
| A•••• C••••• B•• I••• | term loan first lien Investment T••• U••••••••• I•••••• T••• L••• I•••• S+ S••••• 6.50% I••••••• R••• 10.79% A• | $3.0M | $2.7M 94c | SOFR+650 bp |
| A•••• C••••• B•• I••• | revolver first lien Investment T••• S••••• S•••••• R•••••••• L••• I•••• S+ S••••• 6.50% I••••••• R••• 10.79% A | $863,931 | $797,342 95c | SOFR+650 bp |
| A•••• C••••• B•• I••• | equity equity Investment T••• C•••• A U•••• A••••••••• D••• 12/7/2022 | $2,484 | $42,673 17c |
Capital structure as the BDCs see it
latest quarter end Jun 30, 2025
| Facility | Held | On cost | Pricing | Maturity | BDCs |
|---|---|---|---|---|---|
| first lien term loan first lien exited Jun 30, 2025 | at least $9.0M | 94c | SOFR+650 bp | Dec 24, 2029 | 2 |
| first lien revolver first lien exited Jun 30, 2025 | at least $863,931 | 95c | SOFR+650 bp | Dec 22, 2028 | 1 |
| first lien delayed draw term loan first lien exited Dec 31, 2024 | unknown | n/a | SOFR+650 bp | Dec 24, 2029 | 1 |
Equity pieces beside the debt: equity ($42,673 fair value, 1 BDC)
Through time
the borrower's pieces summed across BDCs, every quarter end
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2025 | 2 | $9.9M | $9.1M | 94c | 0 |
| Mar 31, 2025 | 1 | $3.8M | $3.8M | 101c | 0 |
| Dec 31, 2024 | 2 | $13.8M | $13.6M | 101c | 0 |
| Sep 30, 2024 | 1 | $3.5M | $3.5M | 103c | 0 |
All 10 quartersShow fewer
| Quarter end | BDCs | Principal held | Fair value | On cost | PIK pieces |
|---|---|---|---|---|---|
| Jun 30, 2024 | 1 | $3.5M | $3.4M | 102c | 0 |
| Mar 31, 2024 | 1 | $3.5M | $3.5M | 103c | 0 |
| Dec 31, 2023 | 1 | $6.7M | $6.6M | 102c | 0 |
| Sep 30, 2023 | 1 | $3.0M | $3.0M | 103c | 0 |
| Jun 30, 2023 | 1 | $3.0M | $3.0M | 103c | 0 |
| Dec 31, 2022 | 1 | $3.0M | $2.9M | 101c | 0 |
What changed
- Facility left every BDC scheduleJun 30, 2025
- Marked down across lendersJun 30, 2025
- Marked down across lendersJun 30, 2025
- Facility left every BDC scheduleJun 30, 2025
- Marked down (one lender)Jun 30, 2025
Full timeline · 9 eventsShow fewer
- Marked down (one lender)Jun 30, 2025
- Marked down (one lender)Jun 30, 2025
- Facility left every BDC scheduleDec 31, 2024
- Maturity shortened (observed)Dec 31, 2023
Sponsor
No sponsor attribution: no portfolio page, deal announcement or Form D signer consensus names an owner for this borrower group.
Identity
- Group key
- INTERMEDderivedthe codename stem after legal suffixes and deal words
- Spellings
- 2 across 2 BDCsderived
- Industry
- Healthcare & Pharmaceuticalsreportedas one filer wrote it